These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4860569)

  • 21. [Potentiation of contraction in the partially curarized muscle].
    Reinhold H; Hainaut K; Desmedt JE
    J Physiol (Paris); 1970; 62 Suppl 2(2):308. PubMed ID: 5484181
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative assessment of residual antidepolarizing block. I.
    Ali HH; Utting JE; Gray TC
    Br J Anaesth; 1971 May; 43(5):473-7. PubMed ID: 4254031
    [No Abstract]   [Full Text] [Related]  

  • 23. Temperature and potency of d-tubocurarine and pancuronium in vitro.
    Farrell L; Dempsey MJ; Waud BE; Waud DR
    Anesth Analg; 1981 Jan; 60(1):18-20. PubMed ID: 7192944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research on the comparative cumulative effects of d-tubocurarine, toxiferine and diallyl-nor-toxiferine].
    HEROLD M; KABACOFF O; CAHN J
    Agressologie; 1961; 2():375-82. PubMed ID: 13906785
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations in pharmacological responses of rabbit skeletal muscle by reserpine pretreatment.
    Howell RE; Carrier GO
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):205-13. PubMed ID: 7394321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative evaluation of the clinical usefulness of a new muscle relaxant: diallyl-nor-toxiferine].
    Tatarkiewicz-Rosińska J
    Pol Tyg Lek; 1968 May; 23(19):717-20. PubMed ID: 5670216
    [No Abstract]   [Full Text] [Related]  

  • 27. [DIALLYL-BIS-NOR-TOXIFERINE, A DEPOLARIZATION-INHIBITING MUSCLE RELAXANT].
    BAECHTOLD HP; FORNASARI F; HUERLIMANN A
    Helv Physiol Pharmacol Acta; 1964; 22():70-91. PubMed ID: 14221003
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical comparison between tubocurarine and diallylnortoxiferine in children.
    Bush GH
    Br J Anaesth; 1965 Jul; 37(7):540-3. PubMed ID: 5829164
    [No Abstract]   [Full Text] [Related]  

  • 29. Train-of-4 quantitation of competitive neuromuscular block.
    Lee CM
    Anesth Analg; 1975; 54(5):649-53. PubMed ID: 1237253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMPARISON OF THE NEUROMUSCULAR BLOCKING ACTION OF TOXIFERINE, RO 4-3816 AND D-TUBOCURARINE IN THE CAT.
    ICHIYANAGI K; KANAI H; ITO Y
    Acta Med Biol (Niigata); 1963 Aug; 11():81-6. PubMed ID: 14063660
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study between diallylnortoxiferine and tubocurarine.
    Baraka A
    Br J Anaesth; 1967 Aug; 39(8):624-8. PubMed ID: 6035130
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of alcuronium and tubocurarine on blood pressure and heart rate: a clinical comparison.
    Tammisto T; Welling I
    Br J Anaesth; 1969 Apr; 41(4):317-22. PubMed ID: 5780736
    [No Abstract]   [Full Text] [Related]  

  • 33. The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine.
    Castles TR; Loth E; Crawford CR; Lee CC
    J Pharmacol Exp Ther; 1970 Mar; 172(1):44-51. PubMed ID: 5416945
    [No Abstract]   [Full Text] [Related]  

  • 34. Reciprocal potentiation of neuromuscular blocking agents.
    Pleuvry BJ; Hunter AR
    J Pharm Pharmacol; 1968 Jan; 20(1):69-70. PubMed ID: 4384150
    [No Abstract]   [Full Text] [Related]  

  • 35. [A new curarizing drug, Aloferine, in surgery].
    Nalda Felipe MA; Aguado Matorras A; Girón Montañés R; López Rodríguez F; Jurado Simón J
    Rev Esp Anestesiol Reanim; 1970 Apr; 17(2):268-88. PubMed ID: 4249943
    [No Abstract]   [Full Text] [Related]  

  • 36. Sensitivity to tubocurarine and alcuronium with special reference to plasma protein pattern.
    Stovner J; Theodorsen L; Bjelke E
    Anaesthesia; 1971 Jan; 26(1):92. PubMed ID: 5540034
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research on ocular hypotonia caused by alloferine during general anesthesia].
    Tota G; Vagelli A; Busoni P
    Ann Ottalmol Clin Ocul; 1967 Feb; 93(2):171-9. PubMed ID: 5601344
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of diallyl-bis-nor-toxiferine chloride].
    de Freitas PE; Dória Rda S; Carvalho RM; de Araújo EL; de Carvalho RV
    Rev Bras Anestesiol; 1966; 16(4):451-7. PubMed ID: 5998426
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of drugs on acetylcholine release from the cat superior cervical ganglion by carbachol and by preganglionic stimulation.
    McKinstry DN; Koelle GB
    J Pharmacol Exp Ther; 1967 Aug; 157(2):328-36. PubMed ID: 6039824
    [No Abstract]   [Full Text] [Related]  

  • 40. Reevaluation of indirect field stimulation technique to demonstrate oxime effectiveness in OP-poisoning in muscles in vitro.
    Seeger T; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):209-13. PubMed ID: 17250944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.